Antiretroviral-Therapy

Do you have an idea for The New Times to cover? Submit it here!
Search Results for "Antiretroviral-Therapy" (196 articles)
The New Times
Health

What’s driving the decline in new HIV infections?

Saturday, January 17, 2026
Rwanda recorded 2,555 new HIV infections in 2024, down from 2,922 cases in 2023. File
Health

New HIV infections down 12% amid prevention efforts

Friday, January 09, 2026
The New Times
Editorial

Rwanda’s aging HIV population deserves our coordinated support

Wednesday, December 10, 2025
The New Times
Editorial

HIV cure must not be a privilege

Wednesday, December 10, 2025
The New Times
Health

Scientists confirm tenth person cured of HIV

Tuesday, December 09, 2025
The New Times
Health

Rwanda’s aging HIV population needs special attention - experts

Monday, December 01, 2025
Students lead a march to raise awareness about HIV prevention, carrying a banner encouraging young people to get tested, in Rwamagana District, Eastern Province, on May 8. Courtesy.
Health

Rwanda's fight against HIV/AIDS: A closer look at key gains, gaps

Monday, December 01, 2025
A woman takes an HIV test during an HIV prevention campaign in Gasabo in December 2024. Rwanda’s HIV programme supports nearly 230,000 people, with 96.9% on treatment one of the highest coverage rates globally. File
Editorial

Clarity on HIV treatment continuation is important despite halt in USAID funding

Friday, November 28, 2025
People participate in an HIV prevention campaign walk in Ndera Sector, Gasabo District, in December 2024. Dr. Mujawamariya of RBC told The New Times that the Government of Rwanda continues to ensure uninterrupted access to lifesaving ARV medication for all people living with HIV. File
Health

Govt reassures HIV patients as external funding ends

Friday, November 28, 2025
It is now seven months after Rwanda introduced injectable PrEP, a preventive drug for people without HIV.
Health

Rwanda to expand access to HIV preventive injection

Sunday, August 10, 2025
A pharmacist holds a vial of lenacapavir, the new HIV prevention injectable drug, at the Desmond Tutu Health Foundation's Masiphumelele Research Site, in Cape Town, South Africa, Tuesday, July 23, 2024, which was one of the sites for Gilead's lenacapavir drug trial. (AP Photo/Nardus Engelbrecht, File)
Health

Rwanda in talks to get new HIV injectable drug

Tuesday, July 15, 2025
World Health Organization (WHO) Director General Dr. Tedros Adhanom Ghebreyesus virtually delivers his remarks at the conference. All photos by Dan Gatsinzi
Health

IAS Conference opens in Kigali amid warnings over HIV funding cuts

Tuesday, July 15, 2025